Targeting senescent cells for the treatment of age-associated diseases
The Journal of Biochemistry · 2025
DOI: 10.1093/jb/mvae091 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Biochemistry, 2025. Verfasst von Masayoshi Suda und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo City, Tokyo 113-8431, Japan. Hauptthemen laut MEDLINE: Cellular Senescence, Senotherapeutics, Aging, Senescence-Associated Secretory Phenotype. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Cellular senescence, which entails cellular dysfunction and inflammatory factor release—the senescence-associated secretory phenotype (SASP)—is a key contributor to multiple disorders, diseases and the geriatric syndromes. Targeting senescent cells using senolytics has emerged as a promising therapeutic strategy for these conditions. Among senolytics, the combination of dasatinib and quercetin (D + Q) was the earliest and one of the most successful so far. D + Q delays, prevents, alleviates or treats multiple senescence-associated diseases and disorders with improvements in healthspan across various pre-clinical models. While early senolytic therapies have demonstrated promise, ongoing research is crucial to refine them and address such challenges as off-target effects. Recent advances in senolytics include new drugs and therapies that target senescent cells more effectively. The identification of senescence-associated antigens—cell surface molecules on senescent cells—pointed to another promising means for developing novel therapies and identifying biomarkers of senescent cell abundance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo City, Tokyo 113-8431, Japan.
- Division of Endocrinology, Diabetes, & Metabolism, Center for Advanced Gerotherapeutics, Cedars-Sinai Medical Center, 8687 Melrose Ave, Pacific Design Center, West Hollywood, CA 90069, USA.
- Japan Agency for Medical Research and Development-Core Research for Evolutionary Medical Science and Technology (AMED-CREST), Japan Agency for Medical Research and Development, 1-7-1 Otemachi, Chiyoda-ku, Tokyo 100-0004…
Förderung
- NIA NIH HHS
Zitieren
APA
Suda, M., Tchkonia, T., Kirkland, J. L., & Minamino, T. (2025). Targeting senescent cells for the treatment of age-associated diseases. The Journal of Biochemistry. https://doi.org/10.1093/jb/mvae091
Vancouver
Suda M, Tchkonia T, Kirkland JL, Minamino T. Targeting senescent cells for the treatment of age-associated diseases. The Journal of Biochemistry. 2025. doi:10.1093/jb/mvae091
BibTeX
@article{Suda2025,
author = {Suda, Masayoshi and Tchkonia, Tamar and Kirkland, James L and Minamino, Tohru},
title = {Targeting senescent cells for the treatment of age-associated diseases},
journal = {The Journal of Biochemistry},
year = {2025},
doi = {10.1093/jb/mvae091}
}
EUVIMED